asco breast cancer

Release time ：Dec-10,2024

The American Society of Clinical Oncology (ASCO) is a globally leading organization in the field of oncology, committed to the prevention, treatment, and defeat of cancer. Breast cancer is among the most prevalent malignant tumors in women, and early detection and intervention are vital for enhancing survival rates. ASCO releases up-to-date research advancements and treatment guidelines for breast cancer annually, offering clinicians the most current therapeutic strategies and advice.

Typically, breast cancer treatment plans are tailored based on the patient's health, tumor biology, and overall well-being. Treatment options commonly include surgery, radiotherapy, chemotherapy, endocrine therapy, and targeted therapy. For instance, early-stage breast cancer patients often undergo surgical tumor removal first, with subsequent decisions on additional adjuvant therapies based on pathology and molecular marker test results. In cases of advanced or metastatic breast cancer, systemic treatments such as chemotherapy, endocrine therapy, or targeted therapy may be employed to manage tumor growth and spread.

Overall, treating breast cancer is a multidisciplinary effort, necessitating the collaboration of physicians, nurses, dietitians, and psychological counselors. Patients should maintain healthy lifestyle practices, including a balanced diet, regular exercise, and a positive mindset, to optimize treatment outcomes and quality of life. Patients are also advised to closely monitor their health during treatment, seeking medical attention and consulting with their doctors promptly if they experience any discomfort or have concerns.